<p>&nbsp;</p>

<p>Welcome to the fifth edition of Chartis Research’s RiskTech100 report. The RiskTech100 is recognized globally as the most comprehensive and prestigious study of the top technology companies active in the risk management market.</p>

<p>The technology companies covered in this report range from tier-one enterprise software powerhouses to specialised boutiques. What these companies have in common is they all sell licensable software products within the financial services and corporate sectors, and are recognized as being among the best in their chosen sector or risk class. Many of these companies supplement revenues from software sales with implementation and professional services.</p>

<p>We excluded pure-play independent consultants from this study, such as Accenture, Deloitte, Ernst &amp; Young and Capgemini, which are all active in this sector. For the purposes of this study, we focused on companies selling their own software products as part of their overall offering for risk management. Therefore, we included companies like IBM, Towers Watson and Protiviti.</p>

<p>Table of Contents:</p>

<p>1- &nbsp; &nbsp; Overview</p>

<p>2- &nbsp; &nbsp; Integration and Regulation Drive Demand</p>

<p>3- &nbsp; &nbsp; M&amp;A Activity Accelerates</p>

<p>4- &nbsp; &nbsp; Research Methodology</p>

<p>5- &nbsp; &nbsp; How to read the RiskTech100 Rankings</p>

<p>6- &nbsp; &nbsp; RiskTech100 Rankings 2010</p>

<p>7- &nbsp; &nbsp; Category Winners</p>

<p>8- &nbsp; &nbsp; Related Chartis Research</p>

<p>&nbsp;</p>

  • LinkedIn  
  • Save this article
  • Print this page  

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@risk.net or view our subscription options here: http://subscriptions.risk.net/subscribe

You are currently unable to copy this content. Please contact info@chartis-research.com to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Chartis Research? View our subscription options

You need to sign in to use this feature. If you don’t have a Chartis account, please register for an account.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here.